• Iron deficiency is the most prevalent nutrient deficiency in the world • In the United States, iron deficiency with anemia affects 3-5%, and iron deficiency without anemia (IDNA), ~16%, of premenopausal women • Female athletes are more susceptible to IDNA (25-35%), which is 5-7 times more prevalent than iron deficiency with anemia • Iron plays an important role in oxidative metabolism, which is the primary energy pathway for endurance athletes
Methods:
o Cross-sectional study • Subjects:
• Varsity and second-semester novice female rowers who were >18 years of age and able to begin regular training for their sport • Subjects were recruited at the beginning of the conditioning phases of their competitive rowing seasons (on arrival on campus post-summer and post-winter breaks) • A medical screening (NCAA-required) excluded all athletes not healthy enough to participate in their rowing training • Out of 199 eligible female rowers, 165 completed the iron-status screening • Protocol:
• Measured: o Iron-status variables (Hgb, Hct, blood cell count, α-1-acid glycoprotein) o Demographic variables o Current dietary supplement use o Health and menstrual status o Habitual physical activity • Performance was self-reported best times to complete a 2-km simulated race on the ergometer from the previous season (2-3 months before iron status screening) • Performance was later validated with measured performance in a subsample of 48 rowers • Rowers were classified as either iron depleted (sFer <20 µg/L) or normal (sFer 20 µg/L) • Anemic subjects (n = 16) were eliminated from study
Definitions:
• Serum ferritin (sFer): most common index of body-iron stores and reflects iron stored in the liver. sFer can be falsely elevated in an inflammatory state (e.g., infection, postexercise). • Soluble transferrin receptor (sTfR): a transmembrane protein regulated by cellular iron status, reflects iron deficiency at the tissue level and is a more sensitive index of functional iron deficiency than sFer. sTfR is unaffected by inflammation and has been shown to have lower within-subject variability in intense training. • sFer and sTfR respond to iron supplementation in opposite directions (sTfR decreases and sFer increases)
Results:
• 30% (n = 44) of the nonanemic rowers were found to be iron depleted (sFer <20.0 µg/L) • 12% (n = 18) were clinically iron deficient (sFer <12.0 µg/L) • 19% (n = 28) had high values of sTfR (>8.0 mg/L) (early functional iron deficiency) • 10% had total body iron <0 mg/kg (severe iron deficiency)
• 3 had an α-1-acid glycoprotein value >140 mg/dl (inflammation) • 19% of screened subjects had a previous history of anemia or iron deficiency • 33% reported consuming a multivitamin/mineral supplement either intermittently or regularly • No significant interactions between iron status and the amount of time spent in physical activity • Rowers with sFer <20.0 µg/L, 2-km times were 21 s slower than normal iron status (p = .004) • Relationship between sFer status and 2-km time was stronger with sFer <15 µg/L (p = .002)
Discussion:
• 30% prevalence of IDNA in this study similar to previously reported for other female athletes participating in endurance sports • The prevalence of IDNA in this study may have been affected by intake of multivitamin or mineral supplements, some of which contain iron • sFer cutoff of 20 µg/L may have misclassified rowers as normal, and examination of optimal sFer levels for female athletes is warranted • 42% of rowers had sFer <25 µg/L, and the relationship between sFer and reported 2-km performance time remained significant using this cutoff • Did not have measure maximal oxygen consumption or blood lactate in rowers • Menstrual status and high training load were not measured
Applications:
• Strategies to easily screen and improve iron status may be useful for female endurance athletes at the beginning of a training season o Iron status may decrease with increased levels of physical training over time • Early screening and iron supplementation at beginning of training season may help prevent further decrements in iron status throughout training and competitive season o Improve resistance to fatigue and endurance capacity in IDNA nonathletes • It would be important to confirm these results in a longitudinal study
